Diagnostear Technologies Inc (DTR)

Currency in CAD
0.26
+0.01(+4.00%)
Closed·
Trading near 52-week High
Trading near 52-week Low
DTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.250.26
52 wk Range
0.250.26
Key Statistics
Prev. Close
-
Open
0.25
Day's Range
0.25-0.26
52 wk Range
0.25-0.26
Volume
7.5K
Average Volume (3m)
0
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare DTR to Peers and Sector

Metrics to compare
DTR
Peers
Sector
Relationship
P/E Ratio
0.0x−4.2x−0.3x
PEG Ratio
0.000.000.00
Price/Book
0.0x−0.1x2.6x
Price / LTM Sales
0.0x13.8x2.8x
Upside (Analyst Target)
-509.6%66.6%
Fair Value Upside
Unlock0.0%9.1%Unlock

DiagnosTear Technologies Inc., an ophthalmic company, develops and commercializes disruptive diagnostic solutions for eye diseases. It engages in the development of TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform for the identification and monitoring of dry eye syndrome; TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a non-invasive collector of one microliter of tear fluid and subsequent dilution in assay buffer for downstream analytical testing. The company was formerly known as Oceanview Technologies Inc. and changed its name to DiagnosTear Technologies Inc. DiagnosTear Technologies Inc. was incorporated in 2023 and is based in Vancouver, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
26.86M44.63%6.98M
Public Companies & Retail Investors
33.32M55.37%8.66M
Total
60.19M100.00%15.65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BioLight Life Sciences Ltd.44.63%26,864,3936,985

FAQ

What Is the Diagnostear Tech (DTR) Stock Price Today?

The Diagnostear Tech stock price today is 0.26 CAD.

What Stock Exchange Does Diagnostear Tech Trade On?

Diagnostear Tech is listed and trades on the Canadian Securities Exchange.

What Is the Stock Symbol for Diagnostear Tech?

The stock symbol for Diagnostear Tech is "DTR."

What Is the Diagnostear Tech Market Cap?

As of today, Diagnostear Tech market cap is 15.05M CAD.

How Many Times Has Diagnostear Tech Stock Split?

Diagnostear Tech has split 0 times.

What is the current trading status of Diagnostear Tech (DTR)?

As of Oct 31, 2026, Diagnostear Tech (DTR) is trading at a price of 0.26 CAD, with a previous close of 0.00 CAD. The stock has fluctuated within a day range of 0.25 CAD to 0.26 CAD, while its 52-week range spans from 0.25 CAD to 0.26 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.